-
ATXS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Astria Therapeutics (ATXS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 80.90 mm | 80.90 mm | 80.90 mm | 80.90 mm | 80.90 mm | 80.90 mm |
Cash burn (monthly) | 2.16 mm | 3.26 mm | 9.67 mm | 9.68 mm | 9.32 mm | 7.84 mm |
Cash used (since last report) | 9.22 mm | 13.90 mm | 41.30 mm | 41.34 mm | 39.80 mm | 33.48 mm |
Cash remaining | 71.68 mm | 67.00 mm | 39.60 mm | 39.56 mm | 41.10 mm | 47.42 mm |
Runway (months of cash) | 33.2 | 20.6 | 4.1 | 4.1 | 4.4 | 6.0 |
13F holders | Current |
---|---|
Total holders | 106 |
Opened positions | 16 |
Closed positions | 13 |
Increased positions | 34 |
Reduced positions | 38 |
13F shares | Current |
---|---|
Total value | 620.72 bn |
Total shares | 65.22 mm |
Total puts | 9.30 k |
Total calls | 43.10 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
FMR | 7.82 mm | $86.12 bn |
Perceptive Advisors | 6.49 mm | $71.40 bn |
Ra Capital Management | 5.11 mm | $56.21 bn |
Vestal Point Capital | 4.00 mm | $44.04 bn |
Fairmount Funds Management | 3.55 mm | $39.13 bn |
BlackRock | 3.50 mm | $38.53 bn |
VR Adviser | 3.46 mm | $38.08 bn |
Venrock Healthcare Capital Partners III | 3.46 mm | $41.71 mm |
TCG Crossover Management | 2.76 mm | $30.41 bn |
TCG Crossover GP II | 2.76 mm | $33.31 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | Kishbauch Michael D | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Cole Hugh M | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Fred Callori | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Beck Joanne T. | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
5 Jun 24 | Lapointe Anthony Gregg | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |